<DOC>
	<DOCNO>NCT01357356</DOCNO>
	<brief_summary>The purpose study investigate efficacy safety SER120 nasal spray formulation patient nocturia total duration 14 week .</brief_summary>
	<brief_title>Multicenter Study Investigate SER120 Nasal Spray Formulations Patients With Nocturia</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<criteria>Male female 50 year old Nocturia 6 month duration average great 2 nocturic episode per night CHF Diabetis Insipidus Renal Insufficiency Hepatic Insufficiency Incontinence Illness require systemic steroid Malignancy within past 5 year Sleep Apnea Nephrotic Syndrome Unexplained Pelvic Mass Urinary Bladder Neurological dysfunction Urinary Bladder Surgery Radiotherapy Pregnant Breast Feeding</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>